The prognostic impact of NKA dynamics in first-line treatment of metastatic colorectal cancer

被引：0
|
作者：
Nederby, Line
Raunkilde, Louise
Jakobsen, Anders
Jensen, Lars Henrik
Havelund, Birgitte Mayland
Wen, Sara Witting Christensen
Hansen, Torben
机构：
[1] Univ Hosp Southern Denmark, Inst Reg Hlth Res, Vejle Hosp, Dept Biochem & Immunol, Vejle, Denmark
[2] Univ Hosp Southern Denmark, Inst Reg Hlth Res, Vejle Hosp, Danish Colorectal Canc Ctr South, Vejle, Denmark
[3] Univ Hosp Southern Denmark, Inst Reg Hlth Res, Vejle Hosp, Dept Oncol, Vejle, Denmark
[4] Univ Hosp Southern Denmark, Vejle Hosp, Danish Colorectal Canc Ctr South, Vejle, Denmark
[5] Univ Hosp Southern Denmark, Vejle Hosp, Dept Oncol, Vejle, Denmark
[6] Univ Southern Denmark, Inst Reg Hlth Res, Danish Colorectal Canc Ctr South, Dept Oncol,Vejle Hosp, Vejle, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15514
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Bolus fluorouracil and leucovorin with oxaliplatin as first-line treatment in metastatic colorectal cancer
    Ravaioli, A
    Marangolo, M
    Pasquini, E
    Rossi, A
    Amadori, D
    Cruciani, G
    Tassinari, D
    Oliverio, G
    Giovanis, P
    Turci, D
    Zumaglini, F
    Nicolini, M
    Panzini, I
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2545 - 2550
  • [32] Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer
    Karacetin, D.
    Yalcin, B.
    Okten, B.
    Ozturk, S.
    Maral, O.
    Incekara, O.
    JOURNAL OF BUON, 2009, 14 (04): : 605 - 608
  • [33] Bevacizumab in combination with chemotherapy: First-line treatment of patients with metastatic colorectal cancer
    Hochster, Howard S.
    SEMINARS IN ONCOLOGY, 2006, 33 (05) : S8 - S14
  • [34] When to Use Triplet Chemotherapy as First-Line Treatment in Metastatic Colorectal Cancer
    Cremolini, Chiara
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 433 - 435
  • [35] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    Feliu, J.
    Safont, M. J.
    Salud, A.
    Losa, F.
    Garcia-Giron, C.
    Bosch, C.
    Escudero, P.
    Lopez, R.
    Madronal, C.
    Bolanos, M.
    Gil, M.
    Llombart, A.
    Castro-Carpeno, J.
    Gonzalez-Baron, M.
    BRITISH JOURNAL OF CANCER, 2010, 102 (10) : 1468 - 1473
  • [36] Impact of renal impairment on first-line treatment in metastatic urothelial cancer
    Wakeling, S.
    Inderjeeth, A.
    Weickhardt, A. J.
    Lynam, J.
    Gibbs, P.
    O'Haire, S.
    Zlatic, K.
    Wong, S. S. L.
    Sengupta, S.
    Manohar, P.
    Zhang, A.
    Wong, L-M.
    Tran, B.
    Conduit, C. J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1568 - S1569
  • [37] Glasgow PrognosticScore as a Predictor of BevacizumabEfficacy in the First-line Treatment with Metastatic Colorectal Cancer
    Huang, Yuanyuan
    Li, Weiyu
    Quan, Qi
    Zhang, Bei
    Yang, Qiong
    JOURNAL OF CANCER, 2019, 10 (27): : 6858 - 6864
  • [38] First-Line Treatment of Metastatic Pancreatic Cancer
    Tokh, Mohammed
    Bathini, Venu
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2012, 13 (02): : 159 - 162
  • [39] First-line treatment of metastatic breast cancer
    Trudeau, ME
    ANTI-CANCER DRUGS, 1996, 7 : 9 - 12
  • [40] First-line treatment of advanced colorectal cancer
    Hewish, Madeleine
    Cunningham, David
    LANCET, 2011, 377 (9783): : 2060 - 2062
12345